Quick Answer
Medtronic plc reported Cash and Equivalents of $2.22 billion for fiscal year 2025.
Medtronic plc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $2.22B | +72.7% |
| 2024 | $1.28B | -16.8% |
| 2023 | $1.54B | -58.5% |
| 2022 | $3.71B | +3.4% |
| 2021 | $3.59B | -13.2% |
| 2020 | $4.14B | -5.8% |
| 2019 | $4.39B | +19.7% |
| 2018 | $3.67B | -26.1% |
| 2017 | $4.97B | +72.7% |
| 2016 | $2.88B | -40.6% |
| 2015 | $4.84B | +245.2% |
| 2014 | $1.40B | +52.7% |
| 2013 | $919.00M | -21.6% |
| 2012 | $1.17B | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $1.15B | -7.5% | -10.5% |
| October 31, 2025 | $1.28B | -8.0% | +0.7% |
| July 31, 2025 | $1.27B | -2.9% | -42.6% |
| April 30, 2025 | $2.22B | +72.7% | +78.9% |
| January 31, 2025 | $1.24B | -23.6% | -11.0% |
| October 31, 2024 | $1.39B | +6.3% | +6.3% |
| July 31, 2024 | $1.31B | -2.1% | +2.1% |
| April 30, 2024 | $1.28B | -16.8% | -20.9% |
- Medtronic plc showed an increase of +72.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2012–2025 period, Medtronic plc’s cash and equivalents has grown by 89.2% (from $1.17 billion to $2.22 billion).
- The most recent figure is from Medtronic plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on June 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: